ArticleMolecules (Basel, Switzerland)2025
Shedding Light on the Antioxidant Activity of Bee Venom Using a 2,2-Diphenyl-1-Picrylhydrazyl Assay in a Detergent-Based Buffer.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Therapeutic Potential of Bee Venom and Capsicum annum Hydroethanolic Extract in Experimental Model of Rheumatoid Arthritis in Male Rats.Mediators of inflammation · 2026Article
- Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Honeybee venom (HBV) is a complex mixture of proteins and enzymes used in traditional medicine to treat various ailments. HBV has multiple pharmacological effects, making it a promising therapeutic agent in several medical areas. In addition, HBV has many potential cosmetic applications as an anti-aging agent and for the treatment of various skin conditions. HBV's antioxidant properties are also of great interest, as oxidative stress contributes to the onset and progression of many diseases. Several attempts have been made to assess HBV's antioxidant activity, mainly using the DPPH assay. However, variability in experimental protocols and the lack of experimental details make the interpretation of results difficult. In this study, we aim to address the source of this variability by investigating the antioxidant activity of HBV in a detergent-based buffer across a range of pH values (from 3 to 7.5). We also analyze the contribution of melittin, the major component of HBV. Our results demonstrate that the DPPH radical scavenging activity of HBV is strongly influenced by the solvent used and by pH. Specifically, we show, for the first time, that HBV exhibits antioxidant activity under mildly acidic conditions, following a complex fast + slow reaction pattern. Interestingly, melittin contributes only partially to the total antioxidant activity of HBV. Overall, this work provides new insights into the antioxidant properties of HBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.